We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

68 hedge funds and large institutions have $236M invested in IDEAYA Biosciences in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

6% more funds holding

Funds holding: 64 → 68 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.65% less ownership

Funds ownership: 68.24% → 66.59% (-1.6%)

10% less capital invested

Capital invested by funds: $262M → $236M (-$26.6M)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
26
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
+$4.11M
2
PIM
Platinum Investment Management
Australia
+$2.39M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.39M
4
BlackRock
BlackRock
New York
+$2.05M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$3.52M
2
APM
Avidity Partners Management
Texas
-$3.47M
3
AG
Artal Group
Luxembourg
-$2.96M
4
MIM
Monashee Investment Management
Massachusetts
-$1.99M
5
Goldman Sachs
Goldman Sachs
New York
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
5VM
1
5AM Venture Management
California
$43.5M – – –
BI
2
BVF Inc
California
$40.5M – – –
CPX
3
Canaan Partners X
California
$33.4M – – –
BC
4
Boxer Capital
California
$27.7M – – –
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$14.5M +$1.83M +147,400 +15%
APM
6
Avidity Partners Management
Texas
$13.2M -$3.47M -280,300 -21%
BlackRock
7
BlackRock
New York
$11.2M +$2.05M +165,745 +23%
AI
8
Alphabet Inc
California
$9.46M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$8.71M +$2.39M +192,926 +39%
DCM
10
DAFNA Capital Management
California
$4.17M +$4.11M +331,661 New
State Street
11
State Street
Massachusetts
$2.61M +$496K +40,058 +24%
PIM
12
Platinum Investment Management
Australia
$2.43M +$2.39M +193,123 New
Two Sigma Investments
13
Two Sigma Investments
New York
$2.27M +$1.96M +158,124 +692%
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$2.15M -$619K -50,000 -23%
Northern Trust
15
Northern Trust
Illinois
$2.14M +$516K +41,635 +32%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.12M +$673K +54,383 +48%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$1.75M +$1.73M +139,500 New
Renaissance Technologies
18
Renaissance Technologies
New York
$1.69M +$316K +25,500 +23%
EI
19
EAM Investors
California
$1.48M -$63.7K -5,146 -4%
EGI
20
EAM Global Investors
California
$1.2M – – –
N
21
Nuveen
North Carolina
$834K +$164K +13,247 +25%
Squarepoint
22
Squarepoint
New York
$833K +$623K +50,292 +314%
SCM
23
Sio Capital Management
New York
$691K – – –
BCM
24
Bridgeway Capital Management
Texas
$565K -$186K -15,000 -25%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$518K -$194K -15,644 -27%
1
2 3 4

IDYA Hedge Fund Activity: Q3 2020 in Review

68 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2020, worth a combined $236M — down 10% from $262M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IDYA positions and 12 closed out — a net gain of 4 holders — while 26 added to existing stakes and 14 trimmed.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $4.11M. The largest seller was Citadel Advisors, exiting entirely with an estimated $3.52M sold.

  • 68 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2020, up from 64 in Q2 2020.
  • Funds reported $236M of IDEAYA Biosciences stock for Q3 2020, down 10% quarter-over-quarter.
  • 16 funds opened new IDEAYA Biosciences positions in Q3 2020 and 12 closed out, a net change of +4 holders.
  • The largest IDEAYA Biosciences buyer in Q3 2020 was DAFNA Capital Management, an estimated $4.11M added.
  • The largest IDEAYA Biosciences seller in Q3 2020 was Citadel Advisors, an estimated $3.52M sold.

Based on aggregated 13F filings for Q3 2020.